Evaluation of the Clinical Efficacy of Leukine Administered in Conjunction With Paclitaxel in Patients With Advanced Melanoma

Trial Profile

Evaluation of the Clinical Efficacy of Leukine Administered in Conjunction With Paclitaxel in Patients With Advanced Melanoma

Suspended
Phase of Trial: Phase II

Latest Information Update: 09 Dec 2013

At a glance

  • Drugs Sargramostim (Primary) ; Paclitaxel
  • Indications Malignant melanoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top